contact us

Use the form on the right to contact us.

You can edit the text in this area, and change where the contact form on the right submits to, by entering edit mode using the modes on the bottom right.

         

123 Street Avenue, City Town, 99999

(123) 555-6789

email@address.com

 

You can set your address, phone number, email and site description in the settings tab.
Link to read me page with more information.

ardenHEADERnew.png

Arden's Day Blog

Arden's Day is a type I diabetes care giver blog written by author Scott Benner. Scott has been a stay-at-home dad since 2000, he is the author of the award winning parenting memoir, 'Life Is Short, Laundry Is Eternal'. Arden's Day is an honest and transparent look at life with diabetes - since 2007.

type I diabetes, parent of type I child, diabetes Blog, OmniPod, DexCom, insulin pump, CGM, continuous glucose monitor, Arden, Arden's Day, Scott Benner, JDRF, diabetes, juvenile diabetes, daddy blog, blog, stay at home parent, DOC, twitter, Facebook, @ardensday, 504 plan, Life Is Short, Laundry Is Eternal, Dexcom SHARE, 生命是短暂的,洗衣是永恒的, Shēngmìng shì duǎnzàn de, xǐyī shì yǒnghéng de

Filtering by Tag: CGM in the Cloud

Dexcom G5 Mobile App has been updated - iOS

Scott Benner

The Dexcom G5 Mobile App (the app that shares the information to the cloud) has been updated.

iOS users who are running the G5 App on their or their child's device will find an update waiting for them in the app store. Arden has been running it for a week and it's very stable for us. Dexcom Follow apps do not seem to have been recently updated

Click to Enlarge - Info from the Apple App Store

That's pretty much it. Update em' if ya got'em - App Store LINK


Never before seen Dexcom G5 images!

Scott Benner

Dexcom has just announced that the G5 system has been approved today by the FDA and I have some exclusive images for you to check out! There are more images on the announcement page as well as information on release dates, cost and a promo video from Dexcom. Enjoy these and then check out the rest...

Just 24 hours after the surprise FDA approval of the Dexcom G5 continuous glucose monitoring system, I spoke with Dexcom EVP Steven Pacelli and asked him all of the questions about the new G5 that were submitted to me by blog readers and podcast listeners - I even threw in a few of my own. You can listen here, on iTunes or wherever fine podcasts are available.


Dexcom G5 APPROVED by FDA!

Scott Benner

All text taken from the Dexcom press release that can be found in its entirety but this is the stuff you want to know. When you are finished reading this you can check out Dexcom's new G5 webpage.

SAN DIEGO, Aug. 25, 2015 /PRNewswire
FDA Approves Dexcom G5® Mobile Continuous Glucose Monitoring System

Image from Dexcom.com

Dexcom announced today that the U.S. Food and Drug Administration (FDA) has approved the Dexcom G5® Mobile Continuous Glucose Monitoring (CGM) System. With wireless Bluetooth® technology built into the device transmitter, the G5 Mobile CGM System is the first and only fully mobile CGM system approved by the FDA for both adults and children as young as 2 years of age that sends glucose data directly to a smartphone, freeing users from the need to carry a separate receiver.  The new transmitter securely sends vital glucose information directly to an app on iOS-enabled devices for real-time diabetes management. Android applications will follow early next year. Like its predecessor, the G4 PLATINUM CGM with Share, users can also select up to five designated recipients, or "followers".  These followers can remotely monitor a patient's glucose information and receive alert notifications from almost anywhere.

About the Dexcom U.S. G5 Mobile Launch

  • The G5 Mobile system is anticipated to begin shipping in late September 2015. 
  • All purchasers of a G4 Platinum with Share system from August 1, 2015, until the G5 Mobile system is shipped, will be eligible to receive a no-cost upgrade to the G5 Mobile system. 
  • There will be a low cost cash upgrade to the G5 Mobile system for those patients who are still under warranty with their existing system.

Image from Dexcom.com

"Obviously there are a lot of moving parts to our commercial launch plans given this sooner-than-expected approval, and the financial ramifications, such as inventory adjustments and revenue recognition policies are being evaluated and will be discussed in detail on the Q3-2015 earnings call in early November," remarked Sayer.

Dexcom is rapidly advancing technology for continuous glucose monitoring devices to improve diabetes management. Since January, the company has introduced the G4 PLATINUM CGM with Share, apps to enable the first CGM on the Apple Watch™ and now the Dexcom G5® Mobile CGM. These advances are making diabetes management more convenient and flexible than ever before... We are excited for the promise this new technology holds for patients and caregivers.
— Kevin Sayer, President and CEO Dexcom

I'm working on getting you some G5 images, in the meantime check out the link below for my recent podcast conversation with Dexcom CEO Kevin Sayer... back soon.

Great news for the type diabetes community!

Added 8/25/15 10:36am: I got you three NEVER BEFORE seen Dexcom G5 images... 

Added 8/26/16 11:53pm: I spoke with Dexcom EVP Steve Pacelli today. We talked about the G5 approval, launch and more.


Dexcom Announces Google Collaboration

Scott Benner

Dexcom to Collaborate with the Life Sciences Team at Google on the Development of Breakthrough Technologies to Change the Future of Diabetes Management 

Press Release - August 11, 2015

The full press release is here... but these are the parts you care about...

This partnership has the potential to change the face of diabetes technology forever
— Kevin Sayer, President and Chief Executive Officer of Dexcom
Working together, we believe we can introduce products that will move us beyond our core Type 1 business to become the standard of care for all people living with diabetes
— Kevin Sayer

Initial products to be developed under the agreement will focus on minimizing both the cost and size of CGM body worn components. The products will be designed to be disposable, and will be intended for use across all diabetes markets. The goal is to empower more people to control their diabetes with real-time and actionable information by developing a low-cost, small, bandage-sized sensor that is connected to the cloud. By addressing these needs, we believe we will have the platform that can replace finger sticks and become the standard of care.
— Dexcom Press Release
Kevin Sayer

Kevin Sayer

SAN DIEGO--(BUSINESS WIRE)-- DexCom, Inc. (NASDAQ:DXCM), a leader in continuous glucose monitoring (CGM) for people with diabetes, announced today that it has entered into an agreement with the life sciences team at Google to jointly develop a series of next-generation CGM products that are designed to be smaller and less expensive than existing technologies. These new products will incorporate Google's miniaturized electronics platform with DexCom's best-in-class sensor technology. This collaboration also provides an opportunity to better utilize the data generated by these CGM products to significantly improve the outcomes and reduce the costs associated with diabetes care. 


I spoke with Kevin a few days after this announcement for the Juicebox Podcast. It's a great listen if you are interested in Dexcom technology. The show is available on iTunes and wherever you find your podcasts. You can also listen here with this player.